50
Participants
Start Date
January 31, 2002
Primary Completion Date
September 30, 2011
Study Completion Date
September 30, 2012
vinblastine sulphate injection
Vinblastine dose: 6 mg/m\^2 (10 mg max.) route intravenous administration once a week over a period of 10 weeks. If response at week 10 is greater than or equal to stable, weekly Vinblastine will be continued for 42 weeks.
The Hospital for Sick Children, Toronto
Ontario Cancer Research Network
NETWORK
The Hospital for Sick Children
OTHER